Novel Metabolic Signatures of Prostate Cancer Revealed by <sup>1</sup>H-NMR Metabolomics of Urine
Prostate cancer (PC) is one of the most common male cancers worldwide. Until now, there is no consensus about using urinary metabolomic profiling as novel biomarkers to identify PC. In this study, urine samples from 50 PC patients and 50 non-cancerous individuals (control group) were collected. Base...
Main Authors: | Bo Yang, Chuan Zhang, Sheng Cheng, Gonghui Li, Jan Griebel, Jochen Neuhaus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/2/149 |
Similar Items
-
A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
by: Denise Drago, et al.
Published: (2021-05-01) -
Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression
by: Marc Clos-Garcia, et al.
Published: (2018-12-01) -
Influence of Metabolite Extraction Methods on <sup>1</sup>H-NMR-Based Metabolomic Profiling of Enteropathogenic <i>Yersinia</i>
by: Brandon R. Gines, et al.
Published: (2018-11-01) -
Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
by: Marouane Kdadra, et al.
Published: (2019-02-01) -
Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics
by: Ana Rita Lima, et al.
Published: (2021-03-01)